Zachary Klaassen interviews Laurence Albiges about the CaboPoint Phase II Trial. Dr. Albiges discusses the evolving landscape of second-line treatment for clear cell renal cell carcinoma (RCC) after first-line immunotherapy combinations. The CaboPoint study evaluates cabozantinib as a pure second-line treatment in patients who have failed either nivolumab-ipilimumab or an IO-TKI strategy….
BACKGROUND: When human induced pluripotent stem cells (hiPSCs) that CCND2-OE (overexpressed cyclin-D2) were differentiated into cardiomyocytes (CCND2-OEhiPSC-CMs) and administered to the infarcted hearts of immunodeficient…
While cases are climbing in China, the situation is very different from what it was when Covid-19 emerged five years ago, medical experts say. HMPV…
A multibillion-dollar expansion helped the canal accommodate king-size cargo ships. It might also be fueling ecological upheaval.
When new or expectant mothers experience depression in the peripartum period, serious problems can manifest for those children down the line.
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Rana…
“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week.
Oliver Sartor interviews Martin Pomper about radiopharmaceuticals and theranostics in cancer treatment. Dr. Pomper discusses his long-standing interest in the field, highlighting the advantages of…
nephrolithiasis, kidney stones, kidney stone disease, urolithiasis.
For Adam, drinking alcohol was like turning on a Christmas tree. “My brain would light up and I’d want more and more,” he said in…
The FDA published its first draft guidance on the use of AI in the development of drugs and biological products
